Biological significance of short-chain fatty acid metabolism by the intestinal microbiome

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 17, Issue 2, 2014, Pages 139-144

  Puertollano, Elena ^a   Kolida, Sofia ^a   Yaqoob, Parveen ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Gut microbiota; Inflammation; Obesity; Prebiotics; Short chain fatty acids

Indexed keywords

BACTERIA; COLON; FATTY ACIDS, VOLATILE; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; METABOLIC DISEASES; MICROBIOTA; OLIGOSACCHARIDES; PREBIOTICS; RECEPTORS, G-PROTEIN-COUPLED; TRANSCRIPTION FACTORS;

EID: 84894090120     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000025     Document Type: Review

References (54)

1. Scott KP, Gratz SW, Sheridan PO, et al. The influence of diet on the gut microbiota. Pharmacol Res 2013; 69:52-60.
2. Macfarlane GT, Macfarlane S. Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int 2012; 95:50-60.
3. Nyangale EP, Mottram DS, Gibson GR. Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. J Proteome Res 2012; 11:5573-5585.
4. Flint HJ, Scott KP, Duncan SH, et al. Microbial degradation
5. Leonel AJ, Alvarez-Leite JI. Butyrate: implications for intestinal function. Curr Opin Clin Nutr Metab Care 2012; 15:474-479.
6. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001; 81:1031-1064.
7. Charalampopoulos D, Rastall RA. Prebiotics in foods. Curr Opin Biotechnol 2012; 23:187-191.
8. Rastall RA. Gluco and galacto-oligosaccharides in food: update on health effects and relevance in healthy nutrition. Curr Opin Clin Nutr Metab Care 2013; 16:675-678.
9. Macfarlane G, Gibson G. Carbohydrate fermentation, energy transduction and gas metabolism in the human large intestine. In: Mackie R, White B, editors. Gastrointestinal microbiology. USA: Springer; 1997. pp. 269-318.
10. Onumpai C, Kolida S, Bonnin E, Rastall RA. Microbial utilization and selectivity of pectin fractions with various structures. Appl Environ Microbiol 2011; 77:5747-5754.
11. Sarbini SR, Kolida S, Gibson GR, Rastall RA. In vitro fermentation of commercial alpha-gluco-oligosaccharide by faecal microbiota from lean and obese human subjects. Br J Nutr 2013; 109:1980-1989.
12. Sarbini SR, Kolida S, Naeye T, et al. In vitro fermentation of linear and alpha-1,2-branched dextrans by the human fecal microbiota. Appl Environ Microbiol 2011; 77:5307-5315.
13. Hernandez-Hernandez O, Cote GL, Kolida S, et al. In vitro fermentation of alternansucrase raffinose-derived oligosaccharides by human gut bacteria. J Agric Food Chem 2011; 59:10901-10906.
14. Maathuis AJ, van den Heuvel EG, Schoterman MH, Venema K. Galactooligosaccharides have prebiotic activity in a dynamic in vitro colon model using a (13)C-labeling technique. J Nutr 2012; 142:1205-1212.
15. Walton GE, van den Heuvel EG, Kosters MH, et al. A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota inmenandwomen over50years of age. Br JNutr2012;107:1466-1475.
16. Ramnani P, Chitarrari R, Tuohy K, et al. In vitro fermentation and prebiotic potential of novel low molecular weight polysaccharides derived from agar and alginate seaweeds. Anaerobe 2012; 18:1-6.
17. Martinez RC, Cardarelli HR, Borst W, et al. Effect of galactooligosaccharides and Bifidobacterium animalis Bb-12 on growth of Lactobacillus amylovorus DSM 16698, microbial community structure, and metabolite production in an in vitro colonic model set up with human or pig microbiota. FEMS Microbiol Ecol 2013; 84:110-123.
18. Macfarlane S, Cleary S, Bahrami B, et al. Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover study. Aliment Pharmacol Ther 2013; 38:804-816.
19. Lecerf JM, Depeint F, Clerc E, et al. Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. Br J Nutr 2012; 108:1847-1858.
20. Cuervo A, Salazar N, Ruas-Madiedo P, et al. Fiber from a regular diet is directly associated with fecal short-chain fatty acid concentrations in the elderly. Nutr Res 2013; 33:811-816.
21. Conlon MA, Kerr CA, McSweeney CS, et al. Resistant starches protect against colonic DNA damage and alter microbiota and gene expression in rats fed a Western diet. J Nutr 2012; 142:832-840.
22. Haenen D, Zhang J, Souza da Silva C, et al. A diet high in resistant starch modulates microbiota composition, SCFA concentrations, and gene expression in pig intestine. J Nutr 2013; 143:274-283.
23. Engfer MB, Stahl B, Finke B, et al. Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. Am J Clin Nutr 2000; 71:1589-1596.
24. Gnoth MJ, Kunz C, Kinne-Saffran E, Rudloff S. Human milk oligosaccharides are minimally digested in vitro. J Nutr 2000; 130:3014-3020.
25. Hickey RM. The role of oligosaccharides from human milk and other sources in prevention of pathogen adhesion. Int Dairy J 2012; 22:141-146.
26. Chichlowski M, German JB, Lebrilla CB, Mills DA. The influence of milk oligosaccharides on microbiota of infants: opportunities for formulas. Annu Rev Food Sci Technol 2011; 2:331-351.
27. Kitaoka M. Bifidobacterial enzymes involved in the metabolism of human milk oligosaccharides. Adv Nutr 2012; 3:422s-429s.
28. Venema K. Intestinal fermentation of lactose and prebiotic lactose derivatives, including human milk oligosaccharides. Int Dairy J 2012; 22:123-140.
29. Satoh T, Odamaki T, Namura M, et al. In vitro comparative evaluation of the impact of lacto-N-biose I, a major building block of human milk oligosaccharides, on the fecal microbiota of infants. Anaerobe 2013; 19:50-57.
30. Yu ZT, Chen C, Kling DE, et al. The principal fucosylated oligosaccharides of human milk exhibit prebiotic properties on cultured infant microbiota. Glycobiology 2013; 23:169-177.
31. Shen Q, Tuohy KM, Gibson GR, Ward RE. In vitro measurement of the impact of human milk oligosaccharides on the faecal microbiota of weaned formulafed infants compared to a mixture of prebiotic fructooligosaccharides and galactooligosaccharides. Lett Appl Microbiol 2011; 52:337-343.
32. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012; 486:222-227.
33. Oozeer R, van Limpt K, Ludwig T, et al. Intestinal microbiology in early life: specific prebiotics can have similar functionalities as human-milk oligosaccharides. Am J Clin Nutr 2013; 98:561S-571S.
34. Tremaroli V, Fredrik Bäckhed. Functional interactions between the gut microbiota and host metabolism. Nature 2012; 489:242-249.
35. Ye EQ, Chacko SA, Chou EL, et al. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr 2012; 142:1304-1313.
36. Layden BT, Angueira AR, Brodsky M, et al. Short chain fatty acids and their receptors: new metabolic targets. Transl Res 2013; 161:131-140.
37. Waldecker M, Kautenburger T, Daumann H, et al. Inhibition of histonedeacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J Nutr Biochem 2008; 19:587-593.
38. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444:1022-1023.
39. Angelakis E, Armougom F, Million M, Raoult D. The relationship between gut microbiota and weight gain in humans. Future Microbiol 2012; 7:91-109.
40. Samuel BS, Shaito A, Motoike T, et al. Effects of the gut microbiota on host adiposity aremodulated by the short-chain fatty-acid bindingGprotein- coupled receptor, Gpr41. Proc Natl Acad Sci USA 2008; 105:16767-21672.
41. Kimura I, Ozawa K, Inoue D, et al. The gut microbiota suppresses insulinmediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun 2013; 4:1829.
42. Arora T, Loo RL, Anastasovska J, et al. Differential effects of two fermentable carbohydrates on central appetite regulation and body composition. PLoS One 2012; 7:e43263.
43. Lin HV, Frassetto A, Kowalik EJ Jr, et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One 2012; 7:e35240.
44. Tolhurst G, Heffron H, Lam YS, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 2012; 61:364-371.
45. Yadav H, Lee JH, Lloyd J, et al. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J Biol Chem 2013; 288:25088-25097.
46. Maslowski KM, Vieira AT, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009; 461: 1282-1286.
47. Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341:569-573.
48. Nepelska M, Cultrone A, Beguet-Crespel F, et al. Butyrate produced by commensal bacteria potentiates phorbol esters induced AP-1 response in human intestinal epithelial cells. PLoS One 2012; 7:e52869.
49. Zimmerman MA, Singh N, Martin PM, et al. Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells. Am J Physiol Gastrointest Liver Physiol 2012; 302: G1405-G1415.
50. Berndt BE, Zhang M, Owyang SY, et al. Butyrate increases IL-23 production by stimulated dendritic cells. Am J Physiol Gastrointest Liver Physiol 2012; 303:G1384-G1392.
51. Russell WR, Hoyles L, Flint HJ, Dumas ME. Colonic bacterial metabolites and human health. Curr Opin Microbiol 2013; 16:246-254.
52. Aron-Wisnewsky J, Gaborit B, Dutour A, Clement K. Gut microbiota and nonalcoholic fatty liver disease: new insights. Clin Microbiol Infect 2013; 19:338-348.
53. Le Roy T, Llopis M, Lepage P, et al. Intestinal microbiota determines development of nonalcoholic fatty liver disease in mice. Gut 2012. http://www.gut.bmj.com/content/early/2012/11/28/gutjnl-2012-303816.
54. Parnell JA, Raman M, Rioux KP, Reimer RA. The potential role of prebiotic fibre for treatment and management of nonalcoholic fatty liver disease and associated obesity and insulin resistance. Liver Int 2012; 32:701-711.